Neonatal drug withdrawal syndrome Completed Phase 1 Trials for Buprenorphine (DB00921)

Also known as: Drug withdrawal syndrome neonatal / Neonatal Abstinence Syndrome / Neonatal withdrawal symptoms from maternal use of drugs of addiction / Drug withdrawal syndrome in newborn / Withdrawal syndrome neonatal / Neonatal abstinence syndrome (disorder)

IndicationStatusPhase
DBCOND0101857 (Neonatal drug withdrawal syndrome)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01671410Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to BenzodiazepinesTreatment
NCT00521248Buprenorphine for the Treatment of Neonatal Abstinence SyndromeTreatment